Therapeutisches Drug Monitoring von Ceftriaxon Entwicklung, Validierung und klinische Anwendung einer HPLC-Methode

Author： Pauls Christina   Röhr Anka C.   Köberer Andreas   Frey Otto R.  

Publisher： Govi-Verlag

ISSN： 0945-5566

Source： PZ PRISMA, Vol.21, Iss.3, 2014-08, pp. : 177-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Die klinische Entwicklung von Biosimilars

By Brockmeyer Carsten  

Pharmazie in unserer Zeit, Vol. 41, Iss. 6, 2012-11 ,pp. : 461-467

Blackwell Publishing

Access to resources Recommend Favorite

Anforderung an Entwicklung und Qualität von Biosimilars

By Rais Isam  

Pharmazie in unserer Zeit, Vol. 41, Iss. 6, 2012-11 ,pp. : 453-460

Blackwell Publishing

Access to resources Recommend Favorite

Lösungen zum Fragebogen aus Heft 5/14 ,,HIV-Therapeutika – Klinische Anwendung“:

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 437-437

Govi-Verlag

Access to resources Recommend Favorite

Hochleistungsanalytik für die Entwicklung von Biosimilars

By Blüggel Martin  

Pharmazie in unserer Zeit, Vol. 41, Iss. 6, 2012-11 ,pp. : 468-473

Blackwell Publishing

Access to resources Recommend Favorite

HPLC-MS/MS in drug metabolism and pharmacokinetic screening

By Hsieh Yunsheng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 93-101

Informa Healthcare

Access to resources Recommend Favorite